CA959761A - PROCEDE DE SOLUBILISATION DE LA 3.alpha.-HYDROXY-PREGNANE-11,20-DIONE - Google Patents

PROCEDE DE SOLUBILISATION DE LA 3.alpha.-HYDROXY-PREGNANE-11,20-DIONE

Info

Publication number
CA959761A
CA959761A CA019,021*7A CA19021A CA959761A CA 959761 A CA959761 A CA 959761A CA 19021 A CA19021 A CA 19021A CA 959761 A CA959761 A CA 959761A
Authority
CA
Canada
Prior art keywords
procede
pregnane
solubilisation
dione
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA019,021*7A
Other languages
English (en)
Inventor
Guy Pitel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe dEtudes Scientifiques et Industrielles de lIle de France SA
Original Assignee
Societe dEtudes Scientifiques et Industrielles de lIle de France SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe dEtudes Scientifiques et Industrielles de lIle de France SA filed Critical Societe dEtudes Scientifiques et Industrielles de lIle de France SA
Application granted granted Critical
Publication of CA959761A publication Critical patent/CA959761A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA019,021*7A 1967-05-03 1968-05-02 PROCEDE DE SOLUBILISATION DE LA 3.alpha.-HYDROXY-PREGNANE-11,20-DIONE Expired CA959761A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR105231A FR6555M (OSRAM) 1967-05-03 1967-05-03

Publications (1)

Publication Number Publication Date
CA959761A true CA959761A (en) 1974-12-24

Family

ID=8630208

Family Applications (1)

Application Number Title Priority Date Filing Date
CA019,021*7A Expired CA959761A (en) 1967-05-03 1968-05-02 PROCEDE DE SOLUBILISATION DE LA 3.alpha.-HYDROXY-PREGNANE-11,20-DIONE

Country Status (8)

Country Link
US (1) US3769421A (OSRAM)
BE (1) BE714090A (OSRAM)
CA (1) CA959761A (OSRAM)
FR (1) FR6555M (OSRAM)
GB (1) GB1217181A (OSRAM)
IE (1) IE32047B1 (OSRAM)
NL (1) NL142333B (OSRAM)
OA (1) OA03877A (OSRAM)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1379730A (en) * 1970-12-17 1975-01-08 Glaxo Lab Ltd Pharmaceutical compositions
BE863935A (fr) * 1977-02-26 1978-08-14 Basf Ag Utilisation de l'ether 1,2-propylene-glycol-1-n-propylique comme solvant pour preparations pharmaceutiques

Also Published As

Publication number Publication date
IE32047B1 (en) 1973-03-21
OA03877A (fr) 1975-08-14
NL142333B (nl) 1974-06-17
BE714090A (OSRAM) 1968-10-24
GB1217181A (en) 1970-12-31
IE32047L (en) 1968-11-03
NL6806327A (OSRAM) 1968-11-04
US3769421A (en) 1973-10-30
FR6555M (OSRAM) 1968-12-23

Similar Documents

Publication Publication Date Title
CA956641A (en) 1-phenoxy-2-hydroxy-3-sec. alkylamino-propanes
CA690059A (en) PROCEDE DE PREPARATION DE LA 11.alpha.,17.alpha.-DIHYDROXY 16.alpha.-METHYLPREGNANE 3,20-DIONE
CA758069A (en) PROCEDE DE PREPARATION DE 9.alpha.-FLUORO STEROIDES
CA751411A (en) 16.alpha.,17.alpha.-ISOALKYLIDENEDIOXY PREGNENES
CA785277A (en) 2-FLUORO-11-OXYGENATED-4,6-PREGNADIENE-17.alpha.-OL-3,20-DIONES
CA763419A (en) PROCEDE DE PREPARATION DE 3.alpha., 21-DIHYDROXY 11-OXO 20,20 BIS-HYDROXYMETHYL 5.beta.-PREGNANE
CA766748A (en) 1,4-PREGNADIENE-17.alpha.,21-DIOL-3,11,20-TRIONE 17,21-DIACYLATE
CA737452A (en) 16.alpha.-ALKYL-5,6-DIHALO-17.alpha.,21-DIHYDROXY-PREGNAN-3,20-DIONE 21-ACYLATE
CA724654A (en) 16.alpha.-METHYL-9(11)-PREGNEN-17.alpha.-OL-3,20-DIONE
CA785280A (en) 2-FLUORO-9.alpha.-HALO-11-OXYGENATED-17.alpha.-HYDROXY-4,6-PREGNADIENE-3,20-DIONES
CA771646A (en) 3.beta.,5,17.alpha.-TRIHYDROXY-6.beta.-METHYL-16-METHYLENE-5.alpha.-PREGNAN-20-ONE
CA760431A (en) 9.alpha.-FLUORO-PREGNENE-11.beta.,16.alpha.,17.alpha.,21-TETROL-3,20-DIONE-21-ESTERS
AU436736B2 (en) 2,3-epithio-5-androst-6-ene steroids
CA759027A (en) 6,16-dialkyl-17-oxygenated steroids
CA762446A (en) 17,17-difluoro-3-keto-7-alkyl-4-unsaturated steroids
CA767103A (en) 3-OXO 13.beta.-ALCOYL 17.beta.-HYDROXY 17.alpha.-ETHYNYL GONA-5(10),9(11)-DIENES ET PROCEDE DE PREPARATION
CA830982A (en) 6,6-ETHYLENE-9.alpha.-FLUORO STEROIDS
CA726700A (en) 2,9.alpha.-DIFLUORO-6.alpha.-METHYL-11,17.alpha.,21-OXY-4-PREGNENE-3,20-DIONES
CA732606A (en) PROCEDE DE PREPARATION DE 2.alpha.-ALCOYL 19-NOR TESTOSTERONE
CA717975A (en) PROCEDE DE PREPARATION DE DERIVES DE LA 2.alpha.-ALCOYL-9.alpha., 10.alpha.-EPOXY 19-NOR TESTOSTERONE
CA704597A (en) 2.alpha.,6.alpha.-DIMETHYL-11,17-DIOXYGENATED-21-FLUORO-4-PREGNENE-3,20-DIONES
CA804002A (en) 3-OXO 17.alpha.-ETHYNYL GONA-4,9-DIENES
CA769712A (en) 5.beta.,19-CYCLOANDROST-6-ENES
CA758068A (en) 5.beta.,19-CYCLOANDROSTANES
CA764419A (en) PROCEDE DE PREPARATION DE 17.alpha.-CHLOROETHYNYL 17.beta.-HYDROXY 3-OXO .DELTA.4,9-ESTRADIENE